CERVICAL CANCER AND HEPATITIS B VIRUS INFECTION: PREVALENCE, INTERRELATIONSHIP, AND CONTEMPORARY ASPECTS OF PREVENTION
Keywords:
cervical cancer, Hepatitis B virus, HBV infection, human papillomavirus, HPV, viral coinfection, cervical carcinogenesis, vaccination, cervical screening, molecular diagnostics, women’s health, epidemiology, prevention, public health, viral oncology.Abstract
Cervical cancer and Hepatitis B virus (HBV) infection are among the most significant virus-associated public health challenges worldwide. Although persistent infection with high-risk human papillomavirus (HPV) is recognized as the primary cause of cervical cancer, increasing scientific evidence suggests that chronic HBV infection may influence cervical carcinogenesis through immune dysregulation, chronic inflammation, and impaired viral clearance. This study aimed to review the current evidence regarding the prevalence of cervical cancer and HBV infection, evaluate their potential epidemiological and biological relationship, and summarize contemporary preventive strategies. A comprehensive narrative review was conducted using peer-reviewed literature retrieved from PubMed, Scopus, Web of Science, Google Scholar, and publications of the World Health Organization. The reviewed studies indicate that persistent HPV infection remains the principal etiological factor for cervical cancer, whereas HBV may function as an indirect cofactor contributing to disease progression in certain populations. The analysis further demonstrates that universal HBV vaccination, HPV immunization, organized cervical screening programs, molecular diagnostic technologies, and public health education represent the most effective interventions for reducing the burden of both diseases. Despite considerable progress in prevention, substantial disparities continue to exist in low-resource regions due to limited healthcare access, inadequate vaccination coverage, and insufficient screening services. Continued epidemiological surveillance, multidisciplinary collaboration, and high-quality prospective research are required to clarify the relationship between HBV infection and cervical cancer while strengthening integrated prevention strategies. The findings of this review support the implementation of comprehensive public health programs that combine vaccination, early diagnosis, and evidence-based preventive interventions to improve women’s health outcomes worldwide.
References
1. World Health Organization. (2024). Cervical cancer. Geneva, Switzerland: World Health Organization.
2. World Health Organization. (2024). Human papillomavirus (HPV) and cervical cancer. Geneva, Switzerland: World Health Organization.
3. World Health Organization. (2024). Hepatitis B. Geneva, Switzerland: World Health Organization.
4. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
5. Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. The Lancet Global Health, 8(2), e191–e203.
6. International Agency for Research on Cancer. (2022). WHO Classification of Female Genital Tumours (5th ed.). Lyon, France: IARC Press.
7. Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K. M., Hwang, J. P., Jonas, M. M., … & Wang, U. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B guidance. Hepatology, 67(4), 1560–1599.
8. European Association for the Study of the Liver. (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology, 67(2), 370–398.
9. Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M., & Franceschi, S. (2016). Carcinogenic human papillomavirus infection. Nature Reviews Disease Primers, 2, 16086.
10. Bruni, L., Albero, G., Serrano, B., Mena, M., Gómez, D., Muñoz, J., … & de Sanjosé, S. (2023). Human Papillomavirus and Related Diseases Report. ICO/IARC Information Centre on HPV and Cancer.
11. Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019). Cervical cancer. The Lancet, 393(10167), 169–182.
12. Burd, E. M. (2016). Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 29(2), 371–393.
13. World Health Organization. (2020). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva, Switzerland: World Health Organization.
14. Bosch, F. X., Lorincz, A., Muñoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55(4), 244–265.
15. Franco, E. L., Duarte-Franco, E., & Ferenczy, A. (2009). Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 164(7), 1017–1025.